The in vitro induction of T-cell-mediated lympholysis (CML) to trinitrophenyl (TNP)-modified autologous spleen cells has been demonstrated in the mouse (1) . Lysis of modified splenic target cells was obtained when there was K or D serological region homology between the target cells and the cells used in the sensitizing phase (2, 3) . Experiments using F~ responding lymphocytes sensitized and assayed with TNP-modified parental cells indicated that homology between effector and target cells was not sufficient to obtain lysis, but that the homology required was either between modified stimulating and modified target cells, or among responding, modified stimulating and modified target cells (2) . These findings are compatible with the hypothesis that TNP is modifying cell surface components controlled by the K and D serological regions of the major histocompatibility complex, and that the responding lymphocytes are reacting against these new antigenic specificities.
Earlier studies have shown that sensitization of B10.A responding lymphocytes with TNP-modified autologous spleen cells generated effector cells which lysed TNP-modified K-end-matched target cells, but not TNP-modified D-end-matched targets (2, 4) . This finding contrasts with the results obtained with B10.D2 effector cells which lysed TNPmodified H-2K-and H-2D-region-matched targets equally well (2, 4) . This observation was unexpected, since the same D-end products are involved in the new antigenic specificities formed in both strains. This difference in response to TNP-modified H-2D d products of B10.A and B10.D2 splenic lymphocytes has been attributed to a dominant H-2-1inked immune response (/r) gene(s), since (B10.A x B10.D2)F1 lymphocytes generated lytic activity toward TNP-modified H-2D d products when sensitized with B10.A-TNP stimulating cells (4).
Nabholz et al. have demonstrated that the lytic phase of an allogeneic CML can be blocked by antisera directed against the serological region of the target cell to which the responding lymphocytes were sensitized (5). A similar approach has been used in this study to: (a) determine whether antisera directed against H-2 serological specificities expressed by the target cells would affect the lytic phase of the TNP autologous CML, and (b) independently verify by selective blocking with anti-H-2K or D-end sera that in the CML generated by B10.A splenic lymphocytes against TNP-modified autologous cells, only modified Kend products would be involved in the lytic phase, in contrast to B10.D2 in which both K-and D-end products are involved in the lysis.
Material and Methods
Mice. All mice used in the experiments were males, 6-9 wk of age. The C57BL/10 congenic strains and AKR/J mice were purchased from The Jackson Laboratory, Bar Harbor, Maine. The A.TL, A.TH, and A.AL mice used for preparation of antisera were raised in our animal colony from breeders kindly provided by Doctors D. Shreffier and C. David, Department of Human Genetics, University of Michigan, Ann Arbor, Mich. Blocking of Effector Phase with Antisera. A vol of 10/~l containing 5 x 104 TNP-modified '~lCr-labeled target cells was preincubated for 30 min at 37°C with 20 ~l of undiluted normal sera or alloantisera. Based on their known cytotoxic titers for the specificities being studied, these antisera were in antibody excess under the experimental conditions used. The sera were absorbed on TNP-modified spleen cells of the strain of origin in order to remove any natural anti-TNP antibody. 5 x 106 effector cells in a vol of 20/~l were then added to the target cell-antisera mixture, and this was incubated for 3.5 h at 37°C in a CO2 atmosphere for the 5~Cr-release assay (1, 2).
In Vitro Cell
Alloantisera. The antisera used in this study were prepared by immunization of appropriate groups of animals with skin grafts and lymphoid cells as previously described (6) . The following sera were used in this study: B10. 
Results and Discussion
The results shown in Table I The lympholysis of B10.A-TNP targets by effectors generated from sensitization of B10.A and B10.D2 lymphocytes with either TNP-modified autologous or allogeneic spleen cells and the effect of various antisera are shown in Table II . A complete inhibition of lysis by B10.D2 effectors was obtained when the B10.A-TNP targets were preincubated with sera directed against D-end serological specificities (section A). In contrast, this antiserum had no effect on the lysis of targets by B10.A effector cells. Antisera directed against products of K, I-A, and I-B regions of B10.A target cells had no effect on the lysis by B10.D2 effectors, but significantly inhibited the lysis by B10.A effector cells. The data in the lower part of section A demonstrate that these sera have only minimal effects on the lytic capacity of effector cells of these strains directed against H-2 b alloantigens. It is interesting to note that the only appreciable decrease in lysis seen in these allogeneic controls occurred when a possible D-region public specificity was blocked and when B10.D2 but not B10.A was the effector cell donor.
The differential effect of the anti-H-2 d serum on the inhibition of lysis by B10.A and B10.D2 effector cells can be attributed exclusively to differences in the lytic potential of the effector cells, since the same antiserum and target cells were used in both cases. These results demonstrate that inhibition was observed only in the presence of antisera directed against those modified H-2 specificities toward which the effectors were sensitized, and verify that B10. 
D2 cells sensitized against autologous TNP-modified spleen cells appeared to react against both (K, I-A, I-B) d-and H-2Dd-modified components, the influence of sera directed against products of the whole H-2 d complex, (K, I-A, I-B) d regions, (I-C, S, D)
~ regions, and against the shared I-A subregion specificity Ia.8 (6) were examined in the lytic phase assayed on B10.D2-TNP spleen targets. The results, shown in section C of Table II, indicate that a complete inhibition of the lympholysis by B10. D2 cells sensitized against autologous TNP-modified cells was obtained only in the presence of serum directed against products of the whole H-2 complex. Sera directed against either (K, I-A, I-B) d or (I-C, S, D) d regions of the unmodified targets partially inhibited lympholysis, whereas serum against the Ia.8 specificity had no significant effect on CML. Controls indicating that none of these sera affect lympholysis by B10.D2 effectors sensitized against H-2 k alloantigens when assayed on B10.BR- in the table for simplicity, since they do not appear to have a significant effect on target cell lysis in these studies. § NT, not tested.
Selective Effect of Specifically Directed Anti-H-2 Sera and Anti-TNP-KLH Serum on the Lysis of TNP-Modifwd Target Cells by Effector Cells Generated by Sensitization with TNP-Modifled Autologous Stimulating Cells
TNP spleen targets are also shown. It is noteworthy that anti-Ia sera (sections B and C, Table If ) had no appreciable effect on lysis of these splenic targets, despite the fact that at least 50% of spleen cells express Ia antigens (6) . The F(ab)2 fragment of antibodies directed against TNP protect TNP-modified targets from complement-dependent lysis by antisera directed against the unmodified H-2 specificities (A.-M. Schmitt-Verhulst, unpublished observation). This observation suggests that at least some of the TNP groups are closely associated with unaltered H-2 alloantigens. Therefore, we tested whether anti-TNP antibodies would inhibit the lysis of TNP-modified targets by effector cells generated by sensitization with either TNP-modified autologous or unmodified allogeneic sensitizing cells. The data, summarized in Table If , section D, indicate that the lytic phase of the CML of B10.BR effectors sensitized by TNP-modified autologous cells is partially inhibited by sera directed against H-2 k alloantigens and is completely inhibited by serum directed against TNP. The lysis measured on C57BL/10-TNP targets by B10.BR effectors sensitized against unmodified H-2 b alloantigens was not inhibited by the serum directed against the alloantigens of the effector cells (H-2k), but was completely blocked by antisera directed against the TNP present on the target cells. It is also shown in this section, in which B10.BR effector cells are sensitized against unmodified H-2 b alloantigens, that the inhibition of the allogeneic effector phase by anti-TNP serum required the presence of TNP on the target cells. A partial inhibition was also obtained by serum directed against the H-2 b alloantigens. These latter results using anti-TNP sera are compatible with the interpretation that antibodies attached to the haptenic moiety protect the alloantigens from attack by the effector cells. The H-2K and H-2D antigens are known to be located on separate molecules (8) and to migrate independently on the cell surface (9) . The blocking of the effector phase of the TNP-autologous CML with anti-H-2K, anti-H-2D, or anti-TNP sera suggests that some TNP groups are physically closer to the serologically defned antigens than K-and D-region antigens are to each other.
It has recently been found that H-2K or H-2D antigens are functionally associated with the lysis by cells sensitized against non-H-2 alloantigens (10) or sex-associated differences (11) . In the latter case, K-and/or D-region homology was required between stimulator and target cells, but not between effector and target cells for lysis to occur (12) . Ifa unitarian model is to be proposed for H-2K-or H-2D-restricted lysis observed for stimulations involving TNP modification (1-4), viral infection (13-15), and the non-H-2 differences (10, 11), at least two possibilities can be considered: (a) all of the above examples involve activation of T-cell clones recognizing modified H-2 components; or (b) TNP and viral modifications, as well as the other examples (10, 11), do not involve recognition of altered H-2 products, but lysis is effective only on targets sharing H-2K or H-2D antigens with the stimulating cells by some as yet undefined mechanism. The second possibility seems unlikely, since the recognition unit of the effector cell is blocked only by TNP-or viral-modified (2, 13), H-2-matched cells, and not by modified congenic cells that do not share serological region products with the stimulating cells. Furthermore, the examples presented in this report indicate that antibodies to the same D-region antigen do or do not block lysis depending exclusively on the source of the effector cell. This observation would not be expected if any determinant not physically associated with H-2 were the target of lysis. Since a close association between TNP and the H-2 serological region products has been demonstrated in this report, it is difficult to distinguish between a model involving sensitization against modified H-2 products and one encompassing "hapten" in close association with or in the immediate environment of cell surface H-2 products. Summary Splenic lymphocytes from B10.A and B10.D2 mice were sensitized in vitro to trinitrophenyl (TNP)-modified autologous spleen cells. The effector cells generated were assayed in a 51Cr-release assay on TNP-modified syngeneic or congenic spleen target cells. Effector cells from B10.A donors lysed TNP-modified H-2K k-but not H-2D~-region products, whereas B10.D2 effectors reacted with modified products of both the H-2K d and H-2D d regions. As an independent confirmation that this selective K-end lysis by B10.A effector cells is due to an H-2-1inked responder cell defect (4), anti-H-2K k but not anti-H-2D d sera were shown to inhibit the lysis of B10.A-TNP targets by B10.A effectors. In contrast, anti-H-2D d sera inhibited the lysis of B10.A-TNP targets by B10.D2 effectors. Anti-Ia antibodies had no detectable effect on lysis. Anti-TNP-keyhole limpet hemocyanin sera blocked the lysis of TNP-modified targets, irrespective of whether the effector cells were directed against TNP-modified autologous H-2 products or H-2 alloantigens. These results independently verify that B10.A responding lymphocytes do not generate effector cells to TNP-modified H-2D d products, whereas B10.D2 lymphocytes do (4), and suggest that some TNP groups are sterically close to (or part of) the serologically defined H-2K-and H-2D-region antigens.
